US Nears Funding Deal for Moderna's Bird Flu Vaccine Trial
TL;DR Summary
The US government is close to funding a late-stage trial of Moderna's mRNA H5N1 bird flu vaccine, with potential procurement if successful, as the virus spreads among poultry and cattle. Talks with Pfizer for a similar vaccine are ongoing, aiming to bolster the pandemic vaccine stockpile.
- As bird flu spreads in cows, US close to funding Moderna's mRNA H5 vaccine Ars Technica
- US close to deal to bankroll Moderna bird flu vaccine trial Financial Times
- U.S. Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says Forbes
- Moderna Stock Reverses Lower After Confirming U.S. Could Bankroll Its Bird Flu Vaccine Investor's Business Daily
- US government, Moderna nearing deal for bird flu vaccine funding: reports The Hill
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
91%
531 → 46 words
Want the full story? Read the original article
Read on Ars Technica